Effect of JieJiXuanFeiChuYi Granule on Patients with COVID 19 (Omicron): A Randomized Controlled Trial
Phase 1
- Conditions
- Covid 19 (Omicron) infection
- Registration Number
- ITMCTR2200005799
- Lead Sponsor
- The Affiliated Hospital of Changchun University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Meet the diagnostic criteria for patients with Covid 19 in the Covid 19 Pneumonia Diagnosis and Treatment Program (Trial Version 9);
2. The clinical classification is mild and moderate;
3. Diagnosed within 72 hours;
4. Have one or more symptoms of fever, cough, and fatigue;
5. The patient's aged >=18 years;
6. Sign the informed consent.
Exclusion Criteria
1. Severe and Critical type;
2. Women preparing for pregnancy, pregnant and lactating women;
3. Allergic constitution patients (referring to those allergic to two or more drugs or foods or to the known ingredients of the drug in this trial);
4. Mental patients, or patients without self-awareness.
5. Not suitable to participate in clinical trials judged by the investigator.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method